Javed Mohammad

Javed Mohammad began their work experience at Abbott Laboratories in 1995 as a Financial Administrator. Javed then joined Getz Pharma (Pvt) Ltd. in 1997 as the Director of International business and business development and stayed with the company until 2010. Following this, they became the Managing Director of Martin Dow Pharmaceuticals Limited from 2010 to 2012. Javed then served as CEO of BRIOGENE (PVT) LTD from 2012 to 2018. In 2014, Javed Mohammad took on the role of CEO at AJ Research & Pharma, where they successfully developed business operations in various regions. Javed is currently the Group Managing Director and CEO of Martin Dow Limited since 2019.

Javed Mohammad completed their Matriculation degree from BVS Parsi School in 1986. Javed then pursued a Post Graduation in Cost and Management Accountancy with a focus on Financial Management and Cost Accounting at ICMAP from 1992 to 1997.